Excess cardiometabolic risk in children and adolescents initiating antipsychotic treatment compared to young adults: results from a nationwide cohort study
World Psychiatry · 2025-02 · 24 (1) · 103-112
DOI: 10.1002/wps.21279 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift World Psychiatry, online erschienen am 15.01.2025. Verfasst von Mikkel Højlund und 5 weiteren Autor:innen. Beteiligte Einrichtung: Child and Adolescent Mental Health Centre, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Antipsychotic treatment is associated with cardiometabolic risks that may be especially detrimental to children and adolescents. In this Danish population‐based cohort study, we included individuals with psychiatric diagnoses who initiated antipsychotics in 2000‐2021 at age 6‐31 years. We assessed the risk of cardiometabolic adverse events up to 10 years following incident exposure to antipsychotics, compared to age‐ and sex‐matched unexposed individuals with psychiatric diagnoses. Cox regression models were used to calculate hazard ratios (HRs) after adjustment using high‐dimensional propensity scores, including age, sex, calendar time, hospital diagnoses, and prescription drug use. HRs were compared between incident exposure in youths (6‐17 years) and young adults (18‐31 years), and between incident exposure in children (6‐11 years) and adolescents (12‐17 years). The total cohort consisted of 335,093 individuals, including 36,092 subjects exposed to antipsychotics (children and adolescents: 8,547, mean follow‐up: 6.8±3.2 years; young adults: 27,545, mean follow‐up: 6.5±3.4 years) and 299,001 age‐, sex‐ and calendar‐matched unexposed subjects. The incidence rate of cardiometabolic events was higher for young adults initiating antipsychotics than for children and adolescents (23.2 vs. 14.1 events/1,000 person‐years). However, the adjusted excess risk of cardiometabolic events was significantly higher in exposed compared to unexposed children and adolescents (HR=1.87, 95% CI: 1.71‐2.05) than in exposed compared to unexposed young adults (HR=1.46, 95% CI: 1.40‐1.51) (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Child and Adolescent Mental Health Centre, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.
- Department of Psychiatry Aabenraa, Mental Health Services in the Region of Southern Denmark, Aabenraa, Denmark.
- Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Child and Adolescent Psychiatry Southern Denmark, Mental Health Services in the Region of Southern Denmark, Odense, Denmark.
- Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Centre for Pharmacoepidemiology, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Højlund, M., Wesselhoeft, R., Heinrichsen, M., Pagsberg, A. K., Correll, C. U., & Steinhausen, H. C. (2025). Excess cardiometabolic risk in children and adolescents initiating antipsychotic treatment compared to young adults: results from a nationwide cohort study. World Psychiatry, 24(1), 103-112. https://doi.org/10.1002/wps.21279
Vancouver
Højlund M, Wesselhoeft R, Heinrichsen M, Pagsberg AK, Correll CU, Steinhausen HC. Excess cardiometabolic risk in children and adolescents initiating antipsychotic treatment compared to young adults: results from a nationwide cohort study. World Psychiatry. 2025;24(1):103-112. doi:10.1002/wps.21279
BibTeX
@article{Hjlund2025,
author = {Højlund, Mikkel and Wesselhoeft, Rikke and Heinrichsen, Michella and Pagsberg, Anne Katrine and Correll, Christoph U and Steinhausen, Hans-Christoph},
title = {Excess cardiometabolic risk in children and adolescents initiating antipsychotic treatment compared to young adults: results from a nationwide cohort study},
journal = {World Psychiatry},
year = {2025},
volume = {24},
number = {1},
pages = {103--112},
doi = {10.1002/wps.21279}
}
EUVIMED